
UTI - Healthcare Fund - Direct Plan - IDCW
UTI Mutual Fund · Sectoral/Thematic · Direct · IDCW
NAV · as of 10/09/2026
302.10
1D
-0.45%1Y
+17.28%Key stats
- Expense ratio
- 1.28%
- AUM
- ₹1.44 K Cr
- Launched
- 01/01/2013
- Fund manager
- Kamal Gada
- Portfolio turnover
- 0.28%
- Risk
- Very High Risk
- Min lump-sum
- ₹5,000
- Min SIP
- ₹500/mo
- Fresh lump-sum
- Accepted
- Fresh SIP
- Accepted
NAV history
UTI - Healthcare Fund - Direct Plan - IDCW
12/08/2026 to 10/09/2026
O - H - L -
Top holdings
46 disclosed- 1.8.71%
Sun Pharmaceuticals Industries Ltd
Healthcare
- 2.5.57%
Divi's Laboratories Ltd
Healthcare
- 3.4.80%
Ajanta Pharma Ltd
Healthcare
- 4.3.95%
Caplin Point Laboratories Ltd
Healthcare
- 5.3.59%
Lupin Ltd
Healthcare
- 6.3.56%
Gland Pharma Ltd
Healthcare
- 7.3.46%
Apollo Hospitals Enterprise Ltd
Healthcare
- 8.3.10%
Dr Reddy's Laboratories Ltd
Healthcare
- 9.3.10%
Alkem Laboratories Ltd
Healthcare
- 10.2.90%
Net Current Assets
- 11.2.81%
Global Health Ltd
Healthcare
- 12.2.76%
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
- 13.2.68%
Ipca Laboratories Ltd
Healthcare
- 14.2.58%
Fortis Healthcare Ltd
Healthcare
- 15.2.50%
Anthem Biosciences Ltd
Healthcare
- 16.2.41%
Procter & Gamble Health Ltd
Healthcare
- 17.2.34%
Rainbow Childrens Medicare Ltd
Healthcare
- 18.2.20%
Sai Life Sciences Ltd
Healthcare
- 19.2.18%
Jupiter Life Line Hospitals Ltd
Healthcare
- 20.2.17%
Cohance Lifesciences Ltd
Healthcare
- 21.2.17%
Marksans Pharma Ltd
Healthcare
- 22.2.11%
Glenmark Pharmaceuticals Ltd
Healthcare
- 23.1.98%
Viyash Scientific Ltd
Healthcare
- 24.1.94%
Aster DM Quality Care Ltd Ordinary Shares
Healthcare
- 25.1.84%
Aurobindo Pharma Ltd
Healthcare
- 26.1.71%
Sudeep Pharma Ltd
Healthcare
- 27.1.67%
Dr. Lal PathLabs Ltd
Healthcare
- 28.1.64%
Metropolis Healthcare Ltd
Healthcare
- 29.1.61%
Cipla Ltd
Healthcare
- 30.1.55%
Biocon Ltd
Healthcare
- 31.1.33%
Eris Lifesciences Ltd Registered Shs
Healthcare
- 32.1.30%
Vijaya Diagnostic Centre Ltd
Healthcare
- 33.1.21%
Pfizer Ltd
Healthcare
- 34.1.17%
Windlas Biotech Ltd
Healthcare
- 35.1.16%
Alembic Pharmaceuticals Ltd
Healthcare
- 36.1.13%
Blue Jet Healthcare Ltd
Healthcare
- 37.1.02%
Laxmi Dental Ltd
Healthcare
- 38.0.99%
Emcure Pharmaceuticals Ltd
Healthcare
- 39.0.91%
Manipal Health Enterprises Limited
- 40.0.81%
Sanofi Consumer Healthcare India Ltd
Healthcare
- 41.0.81%
Krishna Institute of Medical Sciences Ltd
Healthcare
- 42.0.73%
Aarti Pharmalabs Ltd
Healthcare
- 43.0.73%
Orchid Pharma Ltd
Healthcare
- 44.0.61%
Jubilant Pharmova Ltd
Healthcare
- 45.0.46%
Syngene International Ltd
Healthcare
- 46.0.02%
Clearing Corporation Of India Ltd. Std - Margin
Sector allocation
- Healthcare96.17%
- Unclassified3.83%
Comparable peers
SBI Healthcare Opportunities IDCW Payout Direct Plan
SBI Healthcare Opportunities IDCW Payout (DP) · ₹5.40 K Cr AUM
1Y+22.46%3Y+24.66%-UTI Healthcare IDCW Reinvest Direct Plan
UTI Healthcare IDCW Reinvest (DR) · ₹1.44 K Cr AUM
1Y+17.28%3Y+24.42%-HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.29%3Y+25.53%-HDFC Transportation & Logistics IDCW Payout Direct Plan
HDFC Transportation & Logistics IDCW Payout (DP) · ₹1.96 K Cr AUM
1Y+9.29%3Y+25.53%-HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.29%3Y+25.53%-
Investment objective
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Scheme details
- Scheme code
- 120783
- Fund house
- UTI Mutual Fund
- Category
- Open Ended
- Type
- Equity Scheme
- Sub-category
- Sectoral/Thematic
- Plan
- Direct
- Return type
- IDCW
- ISIN (Growth)
- INF789F01TM3
- ISIN (Div. Reinvest)
- INF789F01TN1
- Tradable on exchange
- No